Dr. Enrico Lallana, MD
Claim this profileKaiser Permanente - Sacramento
Studies Lung Cancer
Studies Brain Metastases
1 reported clinical trial
2 drugs studied
Affiliated Hospitals
More about Enrico Lallana, MD
Clinical Trial Related8 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical TrialsTreatments Enrico Lallana, MD has experience with
- NovoTTF-100M Device
- NovoTTF-200M Device
Breakdown of trials Enrico Lallana, MD has run
Lung Cancer
Brain Metastases
Non-Small Cell Lung Cancer
Brain Tumor
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Enrico Lallana, MD specialize in?
Enrico Lallana, MD focuses on Lung Cancer and Brain Metastases. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are undergoing treatment.
Is Enrico Lallana, MD currently recruiting for clinical trials?
No, Enrico Lallana, MD is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Enrico Lallana, MD has studied deeply?
Yes, Enrico Lallana, MD has studied treatments such as NovoTTF-100M device, NovoTTF-200M device.
What is the best way to schedule an appointment with Enrico Lallana, MD?
Apply for one of the trials that Enrico Lallana, MD is conducting.
What is the office address of Enrico Lallana, MD?
The office of Enrico Lallana, MD is located at: Kaiser Permanente - Sacramento, Sacramento, California 95825 United States. This is the address for their practice at the Kaiser Permanente - Sacramento.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.